Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/34277
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-10-10T11:43:03Z | - |
dc.date.available | 2023-10-10T11:43:03Z | - |
dc.date.issued | 2018 | - |
dc.identifier.citation | Varal, İ. G. vd. (2018). ''Potential use of multi-strain synbiotics for improving postnatal head circumference''. Pakistan Journal of Medical Sciences, 34(6), 1502-1506. | en_US |
dc.identifier.issn | 1682-024X | - |
dc.identifier.uri | https://doi.org/10.12669/pjms.346.16107 | - |
dc.identifier.uri | https://pjms.com.pk/index.php/pjms/article/view/16107 | - |
dc.identifier.uri | http://hdl.handle.net/11452/34277 | - |
dc.description.abstract | Background & Objective: Preterm infants need nutritional and medical requirements in accordance with the physiologic maturity at birth and maintaining optimal postnatal corporal and cerebral growth is one of the main targets of medical caregivers. However, only a few strategies exist to improve the outcomes of infants in a pathogen-rich and nutrient-poor neonatal intensive care unit environment. In this pilot study, we hypothesize that synbiotics may enhance brain growth, which is reflected indirectly by an increase in head circumference through several signalling molecules. Methods: A pilot study was conducted in preterm infants with a gestational age of <= 32 weeks and a birth weight of <= 1500 grams at neonatal intensive care unit of Uludag Univeristy Medical Faculty (NICU) for one-year period. Following the randomization of the infants, a prepared commercial synbiotic solution containing multi-combined probiotics and prebiotics was administered enterally to the study group. Results: The odds of a patient having a lower body weight and head circumference below the 10th percentile were significantly lower in the probiotic group (p=0.001, p=0.03, respectively). Moreover, the infants in the synbiotics group had a more optimal head circumference (between the 50th and 90th percentiles, p=0.001). Conclusions: Our results show that if we can maintain optimal gut microbiota, we might achieve better neuro-development via the beneficial effects of synbiotics on cytokines, neurotransmitters, and the cellular immunity of the nervous system. Further investigational models are needed to demonstrate the beneficial effects of synbiotics on the central nervous system. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Professional Medical Publications | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.rights | Atıf Gayri Ticari Türetilemez 4.0 Uluslararası | tr_TR |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | General & internal medicine | en_US |
dc.subject | Neurodevelopment | en_US |
dc.subject | Newborn | en_US |
dc.subject | Synbiotics | en_US |
dc.subject | Brain-development | en_US |
dc.subject | Preterm infants | en_US |
dc.subject | Neurodevelopment | en_US |
dc.subject | Probiotics | en_US |
dc.subject | Premature | en_US |
dc.subject | Growth | en_US |
dc.subject | System | en_US |
dc.title | Potential use of multi-strain synbiotics for improving postnatal head circumference | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000464432600036 | tr_TR |
dc.identifier.scopus | 2-s2.0-85057002303 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Pediatri Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-6067-3886 | tr_TR |
dc.identifier.startpage | 1502 | tr_TR |
dc.identifier.endpage | 1506 | tr_TR |
dc.identifier.volume | 34 | tr_TR |
dc.identifier.issue | 6 | tr_TR |
dc.relation.journal | Pakistan Journal of Medical Sciences | en_US |
dc.contributor.buuauthor | Varal, İpek Güney | - |
dc.contributor.buuauthor | Köksal, Nilgün | - |
dc.contributor.buuauthor | Özkan, Hilal | - |
dc.contributor.buuauthor | Bağcı, Onur | - |
dc.contributor.buuauthor | Doğan, Pelin | - |
dc.contributor.researcherid | AAG-8393-2021 | tr_TR |
dc.contributor.researcherid | AAI-5981-2020 | tr_TR |
dc.identifier.pubmed | 30559812 | tr_TR |
dc.subject.wos | Medicine, general & internal | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q4 | en_US |
dc.contributor.scopusid | 57197818259 | tr_TR |
dc.contributor.scopusid | 15056452900 | tr_TR |
dc.contributor.scopusid | 16679325400 | tr_TR |
dc.contributor.scopusid | 20733563300 | tr_TR |
dc.contributor.scopusid | 55316686500 | tr_TR |
dc.subject.scopus | Intestine Flora; Ruminococcaceae; Microorganisms | en_US |
dc.subject.emtree | Prebiotic agent | en_US |
dc.subject.emtree | Probiotic agent | en_US |
dc.subject.emtree | Synbiotic agent | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Body weight | en_US |
dc.subject.emtree | Brain growth | en_US |
dc.subject.emtree | Central nervous system | en_US |
dc.subject.emtree | Chemical composition | en_US |
dc.subject.emtree | Clinical effectiveness | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Gestational age | en_US |
dc.subject.emtree | Head circumference | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Infant | en_US |
dc.subject.emtree | Intestine flora | en_US |
dc.subject.emtree | Major clinical study | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Neonatal intensive care unit | en_US |
dc.subject.emtree | Perinatal period | en_US |
dc.subject.emtree | Pilot study | en_US |
dc.subject.emtree | Prematurity | en_US |
dc.subject.emtree | Randomized controlled trial | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Varal_vd_2018.pdf | 296.78 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License